McKesson Co. (NYSE:MCK)’s share price gapped down before the market opened on Tuesday . The stock had previously closed at $153.04, but opened at $149.02. McKesson shares last traded at $146.18, with a volume of 2460984 shares.

A number of equities analysts have recently issued reports on MCK shares. Needham & Company LLC set a $178.00 price target on McKesson and gave the stock a “buy” rating in a research report on Tuesday, October 24th. Credit Suisse Group reissued an “underperform” rating and issued a $130.00 target price (down from $155.00) on shares of McKesson in a research report on Thursday, November 9th. Deutsche Bank assumed coverage on McKesson in a research report on Monday, December 4th. They issued a “buy” rating and a $175.00 target price on the stock. Royal Bank of Canada reissued a “hold” rating and issued a $170.00 target price on shares of McKesson in a research report on Friday, October 27th. Finally, ValuEngine downgraded McKesson from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and ten have issued a buy rating to the company’s stock. McKesson presently has a consensus rating of “Hold” and an average price target of $178.97.

The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.61 and a current ratio of 1.07. The stock has a market cap of $30,470.00, a price-to-earnings ratio of 6.47, a P/E/G ratio of 1.35 and a beta of 1.22.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Thursday, February 1st. The company reported $3.41 EPS for the quarter, beating the consensus estimate of $2.92 by $0.49. McKesson had a net margin of 2.34% and a return on equity of 22.98%. The company had revenue of $53.62 billion for the quarter, compared to analyst estimates of $51.98 billion. During the same period in the prior year, the company earned $3.04 earnings per share. The firm’s revenue was up 7.0% on a year-over-year basis. equities analysts forecast that McKesson Co. will post 12.69 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, April 2nd. Shareholders of record on Thursday, March 1st will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.93%. The ex-dividend date of this dividend is Wednesday, February 28th. McKesson’s payout ratio is 6.02%.

In other McKesson news, Chairman John H. Hammergren sold 65,000 shares of the company’s stock in a transaction on Thursday, December 14th. The shares were sold at an average price of $160.00, for a total value of $10,400,000.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.20% of the stock is currently owned by corporate insiders.

A number of large investors have recently bought and sold shares of MCK. Icon Wealth Partners LLC purchased a new stake in McKesson in the fourth quarter valued at $111,000. WFG Advisors LP boosted its holdings in McKesson by 5.0% in the second quarter. WFG Advisors LP now owns 859 shares of the company’s stock valued at $141,000 after purchasing an additional 41 shares during the last quarter. Wealthcare Advisory Partners LLC purchased a new stake in shares of McKesson during the 3rd quarter worth about $155,000. Focused Wealth Management Inc boosted its stake in shares of McKesson by 650.0% during the 4th quarter. Focused Wealth Management Inc now owns 1,200 shares of the company’s stock worth $187,000 after acquiring an additional 1,040 shares in the last quarter. Finally, Community Financial Services Group LLC purchased a new stake in shares of McKesson during the 4th quarter worth about $204,000. 86.63% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: “McKesson (MCK) Shares Gap Down to $149.02” was originally posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at

McKesson Company Profile

McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with's FREE daily email newsletter.